BioSig Technologies to Present at the 9th Annual LD Micro Main Event

BioSig Technologies, Inc. (BSGM), a medical device company developing the PURE EP(TM) System, a novel cardiac electrophysiology (EP) signal acquisition...

BioSig's CEO on the Cardiac Device Market

We touched base with Greg Cash, CEO of BioSig Technologies, to hear his thoughts on the state of the market...

BioSig Technologies CEO Talks PURE EP System to Treat Complex Cardiac Arrhythmia

Realizing there was a need in the market for a device that can read more complex arrhythmias, BioSig developed the...